RU2016100626A - METHOD FOR PREDICTING THE SEVERITY OF THE COURSE AND THE OUTCOME OF THE DISEASE IN PATIENTS WITH SURGICAL SEPSIS - Google Patents

METHOD FOR PREDICTING THE SEVERITY OF THE COURSE AND THE OUTCOME OF THE DISEASE IN PATIENTS WITH SURGICAL SEPSIS Download PDF

Info

Publication number
RU2016100626A
RU2016100626A RU2016100626A RU2016100626A RU2016100626A RU 2016100626 A RU2016100626 A RU 2016100626A RU 2016100626 A RU2016100626 A RU 2016100626A RU 2016100626 A RU2016100626 A RU 2016100626A RU 2016100626 A RU2016100626 A RU 2016100626A
Authority
RU
Russia
Prior art keywords
ic3ar
disease
monocytes
c3ar
expression
Prior art date
Application number
RU2016100626A
Other languages
Russian (ru)
Other versions
RU2674252C2 (en
Inventor
Анатолий Владимирович Лазанович
Елена Владимировна Маркелова
Игорь Владимирович Кудрявцев
Original Assignee
Государственное бюджетное образовательное учреждение высшего профессионального образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГОУ ВПО ТГМУ Минздрава России)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное бюджетное образовательное учреждение высшего профессионального образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГОУ ВПО ТГМУ Минздрава России) filed Critical Государственное бюджетное образовательное учреждение высшего профессионального образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГОУ ВПО ТГМУ Минздрава России)
Priority to RU2016100626A priority Critical patent/RU2674252C2/en
Publication of RU2016100626A publication Critical patent/RU2016100626A/en
Application granted granted Critical
Publication of RU2674252C2 publication Critical patent/RU2674252C2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Claims (9)

Способ прогнозирования тяжести течения и исхода заболевания у пациентов с хирургическим сепсисом путем исследования крови, отличающийся тем, что у пациентов, в первые 48 часов, после установления диагноза сепсиса, берут 4 мл крови из периферической вены в пробирку с добавлением К3ЭДТА, не более 2-х часов после забора крови, проводят количественную оценку уровня экспрессии C3aR на моноцитах по средней интенсивности флюоресценции на проточном цитометре, в каждой пробе анализируют не менее 104 клеток, далее, в процессе лечения берут повторно кровь, определяют уровень экспрессии C3aR на моноцитах и рассчитывают прогностический индекс IC3aR по формуле:A method for predicting the severity and outcome of a disease in patients with surgical sepsis by blood testing, characterized in that in the first 48 hours after the diagnosis of sepsis, 4 ml of blood is taken from the peripheral vein into a tube with the addition of K 3 EDTA, not more than 2 hours after blood sampling, a quantitative assessment of the level of C3aR expression on monocytes is carried out according to the average fluorescence intensity on a flow cytometer, at least 10 4 cells are analyzed in each sample, then, in the course of treatment, they repeatedly take blood b, determine the level of expression of C3aR on monocytes and calculate the prognostic index IC3aR according to the formula: IC3aR1=N2/N1,IC3aR 1 = N 2 / N 1 , IC3aR2=N3/N1,IC3aR 2 = N 3 / N 1 , IC3aR3=N4/N1,IC3aR 3 = N 4 / N 1 , IC3aR4=N5/N1,IC3aR 4 = N 5 / N 1 , где IC3aR1 - прогностический индекс (с точностью до одного знака после запятой),where IC3aR 1 is the prognostic index (accurate to one decimal place), IC3aR2-5 - прогностический индекс в динамике заболевания,IC3aR 2-5 - prognostic index in the dynamics of the disease, N1 - исходное значение на начальном этапе заболевания (в первые 48 часов) показатель экспрессии на C3aR моноцитах (MFI),N 1 - the initial value at the initial stage of the disease (in the first 48 hours), the indicator of expression on C3aR monocytes (MFI), N2-5 - значение экспрессии на C3aR моноцитах (MFI) при последующих исследованиях в динамике, и при величине IC3aR более 1,0 прогнозируют неблагоприятный прогноз исхода сепсиса.N 2-5 - the value of expression on C3aR monocytes (MFI) in subsequent studies in dynamics, and with an IC3aR value of more than 1.0, an unfavorable prognosis of the outcome of sepsis is predicted.
RU2016100626A 2016-01-11 2016-01-11 Method for predicting disease severity and outcome in patients with surgical sepsis RU2674252C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2016100626A RU2674252C2 (en) 2016-01-11 2016-01-11 Method for predicting disease severity and outcome in patients with surgical sepsis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2016100626A RU2674252C2 (en) 2016-01-11 2016-01-11 Method for predicting disease severity and outcome in patients with surgical sepsis

Publications (2)

Publication Number Publication Date
RU2016100626A true RU2016100626A (en) 2017-07-14
RU2674252C2 RU2674252C2 (en) 2018-12-06

Family

ID=59497081

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016100626A RU2674252C2 (en) 2016-01-11 2016-01-11 Method for predicting disease severity and outcome in patients with surgical sepsis

Country Status (1)

Country Link
RU (1) RU2674252C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2684904C1 (en) * 2018-03-05 2019-04-16 Федеральное государственное бюджетное учреждение науки Оренбургский федеральный исследовательский центр Уральского отделения Российской академии наук Method for assessing severity of sepsis

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2720824C1 (en) * 2019-05-16 2020-05-13 Юрий Леонидович Кецко Method for assessing nearest disease prognosis and protein-energy deficiency correction in patients with inflammatory syndrome of bacterial genesis
RU2713930C1 (en) * 2019-10-16 2020-02-11 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний" (НИИ КПССЗ) Method for prediction of sepsis following cardiosurgical operations performed in conditions of artificial blood circulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2331882C1 (en) * 2006-11-30 2008-08-20 Наталья Валериановна Безручко Method of endogenous intoxication severity evaluation in urgent abdominal pathology in early post-operative period
RU2374646C1 (en) * 2008-05-20 2009-11-27 Федеральное Государственное Учреждение Ростовский НИИ акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Early diagnostic technique for development of neonatal sepsis in newborns suffering from respiratory disorder syndrome and hypoxic damage of cns

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2684904C1 (en) * 2018-03-05 2019-04-16 Федеральное государственное бюджетное учреждение науки Оренбургский федеральный исследовательский центр Уральского отделения Российской академии наук Method for assessing severity of sepsis

Also Published As

Publication number Publication date
RU2674252C2 (en) 2018-12-06

Similar Documents

Publication Publication Date Title
Boeddinghaus et al. Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I
Denfeld et al. The prevalence of frailty in heart failure: a systematic review and meta-analysis
Chen et al. Kinetics of plasma microRNA-499 expression in acute myocardial infarction
Giannitsis et al. Cardiac troponin level elevations not related to acute coronary syndromes
Lee et al. Correlation between circulating VEGF levels and disease activity in rheumatoid arthritis: a meta-analysis.
Safak et al. Association between mean platelet volume levels and inflammation in SLE patients presented with arthritis
Zhao et al. Neutrophil-to-lymphocyte ratio predicts length of stay and acute hospital cost in patients with acute ischemic stroke
CN105525029A (en) Seminal plasma piRNA markers reflecting male sperm activity or combination and application thereof
RU2016100626A (en) METHOD FOR PREDICTING THE SEVERITY OF THE COURSE AND THE OUTCOME OF THE DISEASE IN PATIENTS WITH SURGICAL SEPSIS
Coculescu et al. Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction
Tremblay et al. Biomarkers of vascular complications in type 2 diabetes
Grosjean et al. Under-recognized post-stroke acute kidney injury: risk factors and relevance for stroke outcome of a frequent comorbidity
Keret et al. Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians
Waaijer et al. Assessment of health status by molecular measures in adults ranging from middle-aged to old: Ready for clinical use?
RU2530621C1 (en) Method for evaluating risk of developing cardiovascular complications in females suffering from hypertensive disease
Pagnini et al. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit. correlation with endoscopic'mucosal healing'and implication for management
Uranga et al. Utility of differential white cell count and cell population data for ruling out COVID-19 infection in patients with community-acquired pneumonia
Geyik et al. The relationship between Parkinson’s disease and mean platelet volume
Lung et al. Elementary Laboratory Assays as Biomarkers of Ageing: Support for Treatment of COVID-19?
RU2757522C1 (en) Predicting method for development of chronic kidney disease in patients with type 1 and type 2 diabetes mellitus (options)
JP2020051911A (en) Heart failure marker
RU2572336C1 (en) Method of predicting level of arterial pressure in patents with hypertensive disease
Wen et al. Changes and significance of interleukin 17 expression in patients after renal transplantation
EP4159874A1 (en) Faecal microbiota signature for pancreatic cancer
Khan et al. P2713 Impact of routine implementation of high sensitivity troponin in a state-wide health service

Legal Events

Date Code Title Description
HZ9A Changing address for correspondence with an applicant
TC4A Altering the group of invention authors

Effective date: 20200702